Targeted Therapy of Breast and Gynecological Cancers with Cytotoxic Analogues of Peptide Hormones-Reference-Cited by-同舟云学术

Targeted Therapy of Breast and Gynecological Cancers with Cytotoxic Analogues of Peptide Hormones

Published:2007-08-18 Issue:5 Volume:4 Page:652-658
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Engel Jörg B.¹,Schally Andrew V.¹,Dietl Johannes¹,Rieger Lorenz¹,Hönig Arnd¹

Affiliation:

1. Universitätsfrauenklinik Würzburg, Josef-Schneider-Strasse 4, 97080 Würzburg, Germany, and Miller School of Medicine, University of Miami, Department of Veterans Affairs, VA Medical Center, Research Service 151, 1201 NW 16th Street, Miami, Florida 33125

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp0700514

Reference52 articles.

1. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

2. Chemotherapy targeted to cancers through tumoral hormone receptors

3. New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin

4. High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin.

5. Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-Based Nanocarrier by Targeting with LHRH Peptide: A Promising Approach for Prostate Cancer Radio-Imaging and Therapy;Molecular Pharmaceutics;2024-06-26

2. Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis;Cureus;2023-04-26

3. Synthesis and preliminary evaluation of octreotate conjugates of bioactive synthetic amatoxins for targeting somatostatin receptor (sstr2) expressing cells;RSC Chemical Biology;2022

4. Nanotechnology in the Management of Hormonal Cancer;Hormone Related Cancer Mechanistic and Nanomedicines;2022

5. New drug delivery strategies targeting the GnRH receptor in breast and other cancers;Endocrine-Related Cancer;2021-11-01